China Regenerative Medicine International (HKSE:08158) EV-to-FCF : (As of Apr. 20, 2025)

China Regenerative Medicine International EV-to-FCF Chart

China Regenerative Medicine International Annual Data
	Trend	Apr15	Apr16	Apr17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF		Get a 7-Day Free Trial					-3.89	-215.37	-25.76	35.32	-

China Regenerative Medicine International Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
EV-to-FCF	Get a 7-Day Free Trial															-	-	35.32	-	-

Competitive Comparison of China Regenerative Medicine International's EV-to-FCF

For the Biotechnology subindustry, China Regenerative Medicine International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Regenerative Medicine International's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's EV-to-FCF falls into.

China Regenerative Medicine International EV-to-FCF Calculation

China Regenerative Medicine International's EV-to-FCF for today is calculated as:

China Regenerative Medicine International's current Enterprise Value is HK$160.30 Mil.
China Regenerative Medicine International's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Regenerative Medicine International  (HKSE:08158) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

China Regenerative Medicine International's PE Ratio (TTM) for today is calculated as:

China Regenerative Medicine International's share price for today is HK$0.425.
China Regenerative Medicine International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

China Regenerative Medicine International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

China Regenerative Medicine International Business Description